Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.36 |
| ▸ | ENPP2 | Q13822 | 4/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Tributylmethylammonium SCHEMBL9935351 | 0.83 | BBOX1 (0.42) | TSHRALDH1A1EPHX2ENPP2 | |
| Tributylmethylammonium SCHEMBL9936102 | 0.82 | ENPP2 (0.33) | TSHRALDH1A1ENPP2 | |
| SCHEMBL9935746 | 0.82 | TSHR (0.32) | TSHRALDH1A1 | |
| Tributylmethylammonium SCHEMBL27831904 | 0.78 | EPHX2 (0.46) | EPHX2ENPP2 | |
| Tributylmethylammonium SCHEMBL1627727 | 0.77 | TP53 (0.41) | ENPP2 | |
| SCHEMBL720286 | 0.77 | — | — | |
| Tributylmethylammonium SCHEMBL28478908 | 0.75 | TP53 (0.40) | ENPP2 | |
| Tributylmethylammonium SCHEMBL1618263 | 0.75 | SLC22A1 (0.39) | ENPP2 | |
| SCHEMBL1680935 | 0.74 | — | — | |
| SCHEMBL332175 | 0.74 | DNM1 (0.43) | ENPP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8546609-B2 | Ionic liquid containing allylsulfonate anion | WAKO PURE CHEMICAL INDUSTRIES, LTD. (JP) | 2013-10-01 | — | — | US | disclosed |
| EP-2474527-A1 | IONIC LIQUID CONTAINING ALLYLSULFONATE ANION | Wako Pure Chemical Industries, Ltd. (JP) | 2012-07-11 | — | — | EP | disclosed |
| US-20120157680-A1 | IONIC LIQUID CONTAINING ALLYLSULFONATE ANION | WAKO PURE CHEMICAL INDUSTRIES, LTD. (JP) | 2012-06-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120157680-A1 | IONIC LIQUID CONTAINING ALLYLSULFONATE ANION | ATXN2L, ARL1, INPPL1 | TSHR 2384/4885ALDH1A1 3717/4885EPHX2 4160/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.